Allergan plc. (AGN) financial statements (2021 and earlier)

Company profile

Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
COOLOCK, DUBLIN, D17 E400
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 1,9074,63213,2261,105251
Cash and cash equivalents 8801,8171,7241,096250
Short-term investments 1,0272,81411,50291
Receivables 2,8682,8992,5312,4022,372
Inventory, net of allowances, customer advances and progress billings 8479057181,0102,076
Inventory 8479057181,0102,076
Prepaid expense 421712983265187
Deferred costs    36125
Disposal group, including discontinued operation    3,540949
Assets held-for-sale, not part of disposal group 34   
Other undisclosed current assets 3992,230400258922
Total current assets: 6,47511,37717,8588,6156,882
Noncurrent Assets
Property, plant and equipment 1,7871,7851,6111,5741,595
Long-term investments and receivables 46729511210
Long-term investments 46729511210
Intangible assets, net (including goodwill) 89,609104,511108,975114,48343,710
Goodwill 45,91349,86346,35646,55224,522
Intangible assets, net (excluding goodwill) 43,69554,64862,61967,93219,188
Regulated entity, other noncurrent assets  122   
Disposal group, including discontinued operation, noncurrent assets    8,929 
Other noncurrent assets 84513914854
Other undisclosed noncurrent assets 3,7874244081,979279
Total noncurrent assets: 95,312106,965111,128127,22545,647
TOTAL ASSETS: 101,788118,342128,986135,84152,529
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 4,7875,5415,0194,3504,171
Accounts payable 350325225369645
Accrued liabilities 4,4375,2174,7943,9803,526
Employee-related liabilities     387
Taxes payable     70
Interest and dividends payable     83
Other undisclosed accounts payable and accrued liabilities     (540)
Debt 8684,2322,7982,433697
Restructuring reserve     125
Estimated litigation liability     415
Disposal group, including discontinued operation    1,490 
Deferred revenue and credits   27
Deferred tax liabilities   4747
Other undisclosed current liabilities 7275589(464)
Total current liabilities: 5,7289,8487,8758,3285,019
Noncurrent Liabilities
Long-term debt and lease obligation, including: 22,92925,84429,97140,29314,846
Other undisclosed long-term debt and lease obligation 22,92925,84429,97140,29314,846
Liabilities, other than long-term debt 6,3847,23914,0549,3403,519
Deferred revenue and credits   39
Deferred tax liabilities, net5,5026,35212,9697,9863,062
Liability, pension and other postretirement and postemployment benefits     83
Disposal group, including discontinued operation, liabilities    92 
Other liabilities 8828871,0851,262336
Other undisclosed noncurrent liabilities 1,6161,5748861,290810
Total noncurrent liabilities: 30,92934,65744,91150,92319,175
Total liabilities: 36,65744,50552,78659,25124,194
Stockholders' equity
Stockholders' equity attributable to parent, including: 65,11473,82176,19376,59128,331
Additional paid in capital 56,51054,01453,95968,50828,995
Accumulated other comprehensive income (loss) 1,3451,921(1,038)(494)(465)
Retained earnings (accumulated deficit) 7,25912,95718,3433,648(198)
Other undisclosed stockholders' equity attributable to parent  4,9304,9304,930 
Stockholders' equity attributable to noncontrolling interest 17168(2)4
Total stockholders' equity: 65,13173,83776,20176,58928,336
TOTAL LIABILITIES AND EQUITY: 101,788118,342128,986135,84152,529

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 15,78715,94114,57115,07113,062
Revenue, net15,56814,36014,88713,062
Cost of revenue (8,695)(7,548)(1,861)(4,810)(6,460)
Cost of goods and services sold (2,191)(2,168)(1,861)(4,810)(6,460)
Gross profit: 7,0938,39312,71010,2616,602
Operating expenses (13,340)(14,314)(14,535)(13,327)(8,352)
Other undisclosed operating income    52482
Operating loss: (6,248)(5,921)(1,826)(3,015)(1,268)
Nonoperating expense (609)(4,465)(1,007)(1,416)(444)
Other nonoperating income (expense) 257(3,437)219(234)(42)
Interest and debt expense (30)(1,096)(1,296)(1,193)(382)
Loss from continuing operations before equity method investments, income taxes: (6,887)(11,482)(4,128)(5,624)(2,094)
Income from equity method investments     6
Other undisclosed income from continuing operations before income taxes 301,0961,2961,193376
Loss from continuing operations before income taxes: (6,857)(10,386)(2,832)(4,430)(1,712)
Income tax benefit 1,7716,6701,8971,56282
Loss from continuing operations: (5,086)(3,716)(935)(2,868)(1,630)
Income (loss) from discontinued operations  (403)15,9156,788 
Net income (loss): (5,086)(4,119)14,9803,919(1,630)
Net loss attributable to noncontrolling interest (10)(7)(6)(4)(0)
Net income (loss) attributable to parent: (5,096)(4,126)14,9733,915(1,631)
Preferred stock dividends and other adjustments (46)(278)(278)(232) 
Net income (loss) available to common stockholders, diluted: (5,143)(4,404)14,6953,683(1,631)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss): (5,086)(4,119)14,9803,919(1,630)
Other comprehensive income (loss) (513)2,959(544)(29)(556)
Comprehensive income (loss): (5,599)(1,160)14,4353,891(2,186)
Comprehensive loss, net of tax, attributable to noncontrolling interest (10)(7)(6)(4)(0)
Comprehensive income (loss), net of tax, attributable to parent: (5,609)(1,166)14,4293,887(2,186)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: